Concord Drugs Ltd Q4 FY2024-2025 Results: Summary
Revenue | ₹10.40Cr |
Net Profits | ₹0.04Cr |
Net Profit Margins | 0.38% |
Concord Drugs Ltd’s revenue fell -33.5% since last year same period to ₹10.40Cr in the Q4 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -3.7% fall in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 111.76% since last year same period to ₹0.04Cr in the Q4 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -82.61% fall in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 117.69% since last year same period to 0.38% in the Q4 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -81.94% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Drugs Ltd in Q4 results 2024?
The revenue for Concord Drugs Ltd in the Q4 results 2024 was ₹10.40Cr.
What was the net profit for Concord Drugs Ltd in Q4 results 2024?
The net profit for Concord Drugs Ltd in the Q4 results 2024 was ₹0.04Cr.
What was the net profit margin for Concord Drugs Ltd in Q4 results 2024?
The net profit margin for Concord Drugs Ltd in the Q4 results 2024 was 0.38%.
What was the revenue for Concord Drugs Ltd in Q4 results 2023?
The revenue for Concord Drugs Ltd in the Q4 results 2023 was ₹15.64Cr.
What was the net profit for Concord Drugs Ltd in Q4 results 2023?
The net profit for Concord Drugs Ltd in the Q4 results 2023 was ₹0.34Cr.
What was the net profit margin for Concord Drugs Ltd in Q4 results 2023?
The net profit margin for Concord Drugs Ltd in the Q4 results 2023 was -2.17%.
